Patient-reported factors influencing the treatment decision-making process of older women with non-metastatic breast cancer: a systematic review of qualitative evidence

被引:27
|
作者
Angarita, Fernando A. [1 ]
Elmi, Maryam [1 ]
Zhang, Yimeng [2 ]
Hong, Nicole J. Look [1 ,3 ]
机构
[1] Univ Toronto, Div Gen Surg, Dept Surg, Toronto, ON, Canada
[2] Univ Ottawa, Div Gen Surg, Dept Surg, Ottawa, ON, Canada
[3] Sunnybrook Hlth Sci Ctr, Div Surg Oncol, 2075 Bayview Ave,Room T2 102, Toronto, ON M4N 3M5, Canada
关键词
Breast cancer; Treatment; Clinical decision making; Aged; Older women; ELDERLY-WOMEN; ADJUVANT CHEMOTHERAPY; INTERNATIONAL SOCIETY; RADIATION-THERAPY; INFORMATION NEEDS; OF-LIFE; AGE; RECONSTRUCTION; COMORBIDITY; SURGERY;
D O I
10.1007/s10549-018-4865-0
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PurposeOlder women (70years old) with breast cancer undergo different treatments than young women. Studies have examined factors that influence this disparity, but synthesized patient-reported data are lacking in the literature. This study aims toidentify, appraise, and synthesize the existing qualitative evidence on patient-reported factors influencing older women's decision to accept or decline breast cancer treatment.MethodsA systematic review was performed in accordance with Preferred Reporting Items for Systematic Review and Meta-analysis Protocols (PRISMA) principles. Medline, Embase, CINAHL, and PsycINFO were searched for qualitative studies describing patient-reported factors influencing the decision-making process of older women (70years old) withnon-metastatic invasive breast cancer. Quality was assessed using the Standards for Reporting Qualitative Research (SRQR) criteria. Common ideas were coded, thematically organized, and synthesized within a theoretical framework.ResultsOf 5998 studies identified, 10 met eligibility criteria. The median SRQR total score was 13.04 (IQR 12.84-13.81). The studies represented a range of cancer treatments; most of the studies focused on surgery and primary endocrine therapy. Our data show that the most common patient-reported factors in the decision-making process included treatment characteristics, personal goals/beliefs, patient characteristics, physician's recommendation, and personal/family experience. These factors led the patient to either accept or decline treatment, and were not consistent across all studies included. Studies used different interview guides, which may have affected these results.ConclusionsThis systematic review highlights the complexity of factors that influence an older woman's treatment decision-making process. Acknowledging and addressing these factors may improve discussions about treatment choices between older women and their health care providers, and encourage maximization of a patient-centered approach.
引用
收藏
页码:545 / 564
页数:20
相关论文
共 50 条
  • [31] A Systematic Review of Patient-Reported and Economic Outcomes: Value to Stakeholders in the Decision-Making Process in Patients With Type 2 Diabetes Mellitus
    Vieta, Ana
    Badia, Xavier
    Sacristan, Jose A.
    CLINICAL THERAPEUTICS, 2011, 33 (09) : 1225 - 1245
  • [32] Preserving fertility in women with cancer (PreFer): Decision-making and patient-reported outcomes in women offered egg and embryo freezing prior to cancer treatment
    Vogt, Katharina S.
    Hughes, Jane
    Wilkinson, Anna
    Mahmoodi, Neda
    Skull, Jonathan
    Wood, Hilary
    McDougall, Sophia
    Slade, Pauline
    Greenfield, Diana M.
    Pacey, Allan
    Ledger, William
    Jones, Georgina L.
    PSYCHO-ONCOLOGY, 2018, 27 (12) : 2725 - 2732
  • [33] Factors Influencing Patient Decision-Making in the Treatment of Muscle-Invasive Bladder Cancer
    Desai, Avani
    Bouknight, Lucas
    Reed, Thomas
    Mueller, Dana
    Osterman, Chelsea
    Repka, Michael
    Rose, Tracy
    Smith, Angela B.
    BLADDER CANCER, 2024, 10 (02) : 145 - 155
  • [34] Experiences of Indonesian women with breast cancer underwent treatment decision-making: A qualitative study
    Sitanggang, Yenni Ferawati
    Lin, Hung-Ru
    BELITUNG NURSING JOURNAL, 2024, 10 (04) : 456 - 463
  • [35] Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer
    Julia H. Song
    Olga Kantor
    Elizabeth A. Mittendorf
    Tari A. King
    Christina A. Minami
    Annals of Surgical Oncology, 2022, 29 : 4103 - 4114
  • [36] A Qualitative Study of Breast Cancer Treatment Decisions: Evidence for Five Decision-Making Styles
    Weber, Kirsten M.
    Solomon, Denise Haunani
    Meyer, Bonnie J. F.
    HEALTH COMMUNICATION, 2013, 28 (04) : 408 - 421
  • [37] Oral treatment of metastatic breast cancer with capecitabine: what influences the decision-making process?
    Gornas, M.
    Szczylik, C.
    EUROPEAN JOURNAL OF CANCER CARE, 2010, 19 (01) : 131 - 136
  • [38] Race and Site of Care Impact Treatment Delays in Older Women with Non-Metastatic Breast Cancer
    Song, Julia H.
    Kantor, Olga
    Mittendorf, Elizabeth A.
    King, Tari A.
    Minami, Christina A.
    ANNALS OF SURGICAL ONCOLOGY, 2022, 29 (07) : 4103 - 4114
  • [39] DECISION-MAKING ABOUT BREAST CANCER TREATMENT AMONG OLDER AFRICAN AMERICAN WOMEN
    Martin, S. S.
    Csikai, E. L.
    Batey, D.
    Peterson, T. L.
    Harmon, D. K.
    Broussard, C.
    Taylor, J. K.
    GERONTOLOGIST, 2012, 52 : 48 - 48
  • [40] Decision-making around breast cancer treatment among women aged 80 and older
    Schonberg, M. A.
    Silliman, R. A.
    Marcantonio, E. R.
    JOURNAL OF GENERAL INTERNAL MEDICINE, 2008, 23 : 274 - 275